Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainAnk_2

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

3.54e-05215546PF12796
DomainAnk

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

4.91e-05228546PF00023
Domain-

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

7.82e-052485461.25.40.20
DomainANK

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

8.35e-05251546SM00248
DomainANK_REPEAT

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

8.73e-05253546PS50088
DomainAnkyrin_rpt-contain_dom

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

8.92e-05254546IPR020683
DomainANK_REP_REGION

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

8.92e-05254546PS50297
DomainAnkyrin_rpt

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

1.06e-04262546IPR002110
Domain-

MED16 CIAO1 BIRC6 DDB2 WDR59 WDTC1

3.86e-043335462.130.10.10
DomainWD40/YVTN_repeat-like_dom

MED16 CIAO1 BIRC6 DDB2 WDR59 WDTC1

3.98e-04335546IPR015943
DomainWD40

MED16 CIAO1 DDB2 WDR59 WDTC1

8.96e-04259545PF00400
DomainWD40

MED16 CIAO1 DDB2 WDR59 WDTC1

1.04e-03268545SM00320
DomainWD40_repeat

MED16 CIAO1 DDB2 WDR59 WDTC1

1.12e-03272545IPR001680
DomainWD_REPEATS_1

MED16 CIAO1 DDB2 WDR59 WDTC1

1.23e-03278545PS00678
DomainWD_REPEATS_2

MED16 CIAO1 DDB2 WDR59 WDTC1

1.25e-03279545PS50082
DomainWD_REPEATS_REGION

MED16 CIAO1 DDB2 WDR59 WDTC1

1.25e-03279545PS50294
DomainWD40_repeat_dom

MED16 CIAO1 DDB2 WDR59 WDTC1

1.64e-03297545IPR017986
DomainFERM_C

PTPN13 EPB41L4B

2.55e-0326542PF09380
DomainFERM_C

PTPN13 EPB41L4B

2.75e-0327542SM01196
DomainFERM_PH-like_C

PTPN13 EPB41L4B

2.75e-0327542IPR018980
DomainFERM_N

PTPN13 EPB41L4B

4.09e-0333542PF09379
DomainFERM_N

PTPN13 EPB41L4B

4.09e-0333542IPR018979
DomainFERM_M

PTPN13 EPB41L4B

7.83e-0346542PF00373
Domain-

PTPN13 EPB41L4B

8.85e-03495421.20.80.10
DomainFERM_central

PTPN13 EPB41L4B

8.85e-0349542IPR019748
DomainFERM_domain

PTPN13 EPB41L4B

8.85e-0349542IPR000299
DomainFERM_1

PTPN13 EPB41L4B

9.20e-0350542PS00660
DomainFERM_2

PTPN13 EPB41L4B

9.20e-0350542PS00661
DomainFERM_3

PTPN13 EPB41L4B

9.20e-0350542PS50057
DomainBand_41_domain

PTPN13 EPB41L4B

9.20e-0350542IPR019749
DomainB41

PTPN13 EPB41L4B

9.20e-0350542SM00295
DomainFERM/acyl-CoA-bd_prot_3-hlx

PTPN13 EPB41L4B

9.20e-0350542IPR014352
Domain-

BIRC6 WDR59

9.56e-03515423.10.110.10
DomainUBQ-conjugating_enzyme/RWD

BIRC6 WDR59

1.03e-0253542IPR016135
Pubmed

DDB1 binds histone reader BRWD3 to activate the transcriptional cascade in adipogenesis and promote onset of obesity.

MED16 MED23 DDB2 WDR59 WDTC1

5.24e-079955534161765
Pubmed

Characterization of large-scale genomic differences in the first complete human genome.

KLRC2 KLRC3

2.46e-06255237403156
Pubmed

CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation.

CIAO1 DDB2 WDR59

1.19e-052855317041588
Pubmed

Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.

KLRC2 KLRC3

1.47e-0545528943374
Pubmed

Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain.

TRPA1 CNR2

1.47e-05455232687056
Pubmed

The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex.

KLRC2 KLRC3

2.45e-0555529683661
Pubmed

The Sensory Coding of Warm Perception.

TRPA1 TRPM2

2.45e-05555232208171
Pubmed

Homozygous MED25 mutation implicated in eye-intellectual disability syndrome.

MED16 MED23

2.45e-05555225792360
Pubmed

Development and function of CD94-deficient natural killer cells.

KLRC2 KLRC3

2.45e-05555221151939
Pubmed

Structural basis for NKG2A/CD94 recognition of HLA-E.

KLRC2 KLRC3

3.67e-05655218448674
Pubmed

Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.

KLRC2 KLRC3

3.67e-05655211751968
Pubmed

Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes.

KLRC2 KLRC3

5.13e-0575529598306
Pubmed

High affinity binding of Dab1 to Reelin receptors promotes normal positioning of upper layer cortical plate neurons.

POU3F3 LRP8

5.13e-05755215249135
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MAN2B1 ZNF316 ANKRD11 MIB2 ATG9A PUM1 BIRC6 TTC38 WDR59

5.46e-05110555935748872
Pubmed

Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing.

KLRC2 KLRC3

6.83e-05855233765134
Pubmed

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.

KLRC2 KLRC3

6.83e-05855210601355
Pubmed

Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3ζ via deacetylation of lysines within the 14-3-3ζ binding pocket.

BAD ATG9A

8.78e-05955225770209
Pubmed

A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery.

DDB2 WDTC1

8.78e-05955219966799
Pubmed

Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.

KLRC2 KLRC3

8.78e-05955214707119
Pubmed

Physiological significance of proteolytic processing of Reelin revealed by cleavage-resistant Reelin knock-in mice.

POU3F3 LRP8

1.10e-041055232161359
Pubmed

Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9.

BAD ATG9A

1.34e-041155225266655
Pubmed

A novel docking site on Mediator is critical for activation by VP16 in mammalian cells.

MED16 MED23

1.89e-041355214657022
Pubmed

CDK8 is a positive regulator of transcriptional elongation within the serum response network.

MED16 MED23

1.89e-041355220098423
Pubmed

Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration.

POU3F3 LRP8

2.21e-041455221460838
Pubmed

Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3.

MED16 MED23

2.54e-041555218418385
Pubmed

Human and mouse proteases: a comparative genomic approach.

USP30 USP11 OVCH1

2.93e-048155312838346
Pubmed

Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.

MED16 MED23

3.29e-041755210235266
Pubmed

Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia.

TRPA1 TRPM2

3.70e-041855231911949
Pubmed

CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.

USP30 USP11 CIAO1 TMLHE PUM1 WDR59

3.84e-0460655636538041
Pubmed

Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors.

MED16 MED23

4.58e-042055215340084
Pubmed

Transcriptional regulation of cortical neuron migration by POU domain factors.

POU3F3 LRP8

4.58e-042055211859196
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

FUT10 PTPN13 EPB41L4B TRPM2 BAD ANKRD11 BOD1L1 INVS LRP8

5.06e-04148955928611215
Pubmed

The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro.

MED16 MED23

5.56e-042255211867769
Pubmed

ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.

MED16 MED23 WDTC1

6.61e-0410755320508642
Pubmed

Mapping the expression of transient receptor potential channels across murine placental development.

TRPA1 TRPM2

6.63e-042455233884443
Pubmed

International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.

TRPA1 TRPM2

7.20e-042555216382100
Pubmed

Subunit architecture and functional modular rearrangements of the transcriptional mediator complex.

MED16 MED23

7.79e-042655224882805
Pubmed

Novel critical role of a human Mediator complex for basal RNA polymerase II transcription.

MED16 MED23

7.79e-042655211559591
Pubmed

Mediator complex proximal Tail subunit MED30 is critical for Mediator core stability and cardiomyocyte transcriptional network.

MED16 MED23

7.79e-042655234506481
Pubmed

An introduction to TRP channels.

TRPA1 TRPM2

8.40e-042755216460286
Pubmed

Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.

ANKK1 DDX60 ANKRD11 BOD1L1

9.12e-0427255431010829
Pubmed

A mammalian mediator subunit that shares properties with Saccharomyces cerevisiae mediator subunit Cse2.

MED16 MED23

9.70e-042955214638676
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

DNAH3 EPB41L4B ZNF316 BOD1L1 LRRC70 BIRC6

1.06e-0373655629676528
Pubmed

The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.

MED16 MED23

1.11e-033155223322298
Pubmed

Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.

DDB2 WDTC1

1.18e-033255216964240
Pubmed

Cold-induced protein RBM3 orchestrates neurogenesis via modulating Yap mRNA stability in cold stress.

TRPA1 TRPM2

1.26e-033355230037926
Pubmed

Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.

USP30 USP11

1.26e-033355230323974
Pubmed

A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.

TRPA1 TRPM2

1.26e-033355219834762
Pubmed

TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.

MED16 MED23

1.26e-033355233567268
Pubmed

MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.

MED16 MED23

1.33e-033455215989967
Pubmed

Host PDZ-containing proteins targeted by SARS-CoV-2.

PTPN13 RIMS2

1.41e-033555233864728
Pubmed

MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer.

ATG9A BIRC6 DDB2

1.44e-0314055320819778
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

PTPN13 EPB41L4B USP11 BOD1L1

1.53e-0331355438270169
Pubmed

Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.

MAN2B1 NLRP2 BIRC6 KLB

1.53e-0331355420800603
Pubmed

A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

DDB2 WDTC1

1.58e-033755216949367
Cytoband4q32.3

TRIM61 DDX60

8.00e-04345624q32.3
GeneFamilyAnkyrin repeat domain containing

ANKK1 TRPA1 ANKRD11 MIB2 ANKRD23 INVS

2.18e-05242436403
GeneFamilyCD molecules|C-type lectin domain family|Killer cell lectin like receptors

KLRC2 KLRC3

3.59e-0412432621
GeneFamilyWD repeat domain containing

MED16 CIAO1 DDB2 WDR59 WDTC1

3.78e-04262435362
GeneFamilyTransient receptor potential cation channels

TRPA1 TRPM2

2.01e-0328432249
GeneFamilyCyclins|Mediator complex

MED16 MED23

2.78e-03334321061
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

KLRC2 KLRC3

4.27e-03414321298
GeneFamilyAnkyrin repeat domain containing|FERM domain containing

PTPN13 EPB41L4B

6.30e-03504321293
GeneFamilyUbiquitin specific peptidases

USP30 USP11

7.84e-0356432366
ToppCellCOVID-19_Severe-NK_activated|COVID-19_Severe / Disease condition and Cell class

DDX60 MYOM2 NLRP2 TTC38 KLRC2 KLRC3

1.93e-07200566f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8
ToppCell10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

MIB2 MYOM2 TTC38 KLRC2 KLRC3

3.68e-06186565165d02be3b3eaeb8784a2b0b2020928b21a19bc7
ToppCellCOVID-19_Mild-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Mild / Disease group, lineage and cell class

DDX60 MYOM2 TTC38 KLRC2 KLRC3

3.88e-061885651aecae0d94905bfbd414adf1450035e5b863abe7
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

3.98e-06189565eb5b107dbc50e538dc27ba2867b196a23a8054bf
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

3.98e-06189565c6760ea8ecca6abdd9eb067f3b3f4eea9420b852
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

3.98e-06189565af5f92dc3b3bc6acacd633981b8ef7f0c593c92e
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

3.98e-0618956504bdcf05b8c72c13e7d35d1c7444f50374d41203
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.41e-0619356554604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8
ToppCellICU-NoSEP-Lymphocyte-T_NK-NK|ICU-NoSEP / Disease, Lineage and Cell Type

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.52e-06194565090edfc884655e5ab38b027c6e1a5aa809ebb19d
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.52e-0619456552e09b14159b609af00264a8f38accf37ba8f464
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.75e-0619656578b28b263deaa43590b38597186222c6447ad25f
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.75e-061965653e78e307c9c991c1aadc85c61d401431cf75eaec
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.75e-06196565f0566f2ef96584ed6d9247b149218376fb509915
ToppCellCOVID-19_Severe-NK|World / disease group, cell group and cell class

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.75e-06196565f46ca7cc2d8407d0dcaa77c4b16a2c1f2a23734d
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.87e-061975652abe27f6722fa0dab801bca4cd19e34c1fb4173e
ToppCellCOVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class

DDX60 MYOM2 TTC38 KLRC2 KLRC3

4.87e-061975654711ecb157e907758a5021248ae8b043d17672c6
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.87e-06197565300849a922722adcbc068593fc5cc0bef936d9cb
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.87e-06197565a97c4a9eb89260b0b5745834ccef9d558d857f93
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

4.87e-06197565bc37b8919f98dc18c2200834405f06823d965d78
ToppCellHealthy_donor-NK|World / disease group, cell group and cell class (v2)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

5.00e-061985654c9c40e91173836ad0df2eba635a4cb3385e80c6
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.00e-06198565ce92d5fbc2eac27fb246b044fb1914ab92506275
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.00e-06198565fed823d6e684d113bcc9ff3cd1803bb001aa02fa
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.00e-061985650e918e9db9b884f5328d438e90efe065e27266ee
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.00e-061985651ef3a6bd681c223eed58300348adfef89df5563c
ToppCellHealthy/Control-NK|World / Disease group and Cell class

MIB2 MYOM2 TTC38 KLRC2 KLRC3

5.12e-0619956587af9c38938dc2db0f9cf9f3676895d2a8b5d7e6
ToppCellCOVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.12e-06199565edf5f80b4c299e6bf462675f2cd3329d86c923d8
ToppCellHealthy/Control-NK|Healthy/Control / Disease group and Cell class

MIB2 MYOM2 TTC38 KLRC2 KLRC3

5.12e-06199565e7fd91080fca7c31a2d48433791da3c2a4adf14d
ToppCellHealthy_donor-NK|Healthy_donor / disease group, cell group and cell class (v2)

MIB2 MYOM2 TTC38 KLRC2 KLRC3

5.12e-061995654892d85f7c8c00e5afdcea2cd7bae0074322fa52
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK-NK|ICU-NoSEP / Disease, condition lineage and cell class

MIB2 MYOM2 TTC38 KLRC2 KLRC3

5.25e-062005656d1e927c4498dc8a6152c211d414f719d9c1f436
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.25e-062005656a77f9643646bafc1157bf1fc1e4c614860ee642
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class

DDX60 MYOM2 TTC38 KLRC2 KLRC3

5.25e-062005657751affe353a5208ffad7a58308c588050e77243
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D2|367C / Donor, Lineage, Cell class and subclass (all cells)

TTC38 KLRC2 KLRC3 CNR2

3.61e-0514856499536d36c2ab5fac92765dac4fd8827a9368b181
ToppCellThalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Ebf1_(Anterior_pretectal_nucleus_(APT))-|Thalamus / BrainAtlas - Mouse McCarroll V32

TRPA1 SLC22A13 KLB

5.10e-0557563ef44602342511a9f90c93463628ad8b154cb26fb
ToppCellThalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Ebf1_(Anterior_pretectal_nucleus_(APT))|Thalamus / BrainAtlas - Mouse McCarroll V32

TRPA1 SLC22A13 KLB

5.10e-0557563a3dc14f7a63cc70b2789770644e0b9453426c6f9
ToppCellBronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X

HCAR3 EPB41L4B TMLHE INVS

5.14e-05162564985adca17b0c99563feef7910f3da5df31e636b6
ToppCelldroplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

USP30 DDX60 MIB2 CNR2

5.52e-051655641d0f60bf47a40ac916f0fcb5532a968742a0edbb
ToppCellfacs-Heart-LA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDB2 KLRC2 KLRC3 LRP8

5.92e-0516856416c3313c4186fa327d71215f8eebc31fc12ff1c0
ToppCellfacs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDB2 KLRC2 KLRC3 LRP8

5.92e-0516856424d1e0a05cda09ee3b80208d75cb2b601023f3bf
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FUT10 ZNF316 MYOM2 TTC38

5.92e-0516856494cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7
ToppCellfacs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDB2 KLRC2 KLRC3 LRP8

5.92e-05168564b952af95a68888adedd03b1b60836d18524611ab
ToppCellT_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

EPB41L4B MYOM2 TTC38 PGBD2

6.34e-0517156404c811817cfec45af5f2891793106cc7ddb0300e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYOM2 TTC38 KLRC2 KLRC3

6.49e-0517256486f52f486d67217fc1b8443ab362c975df2974a4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYOM2 TTC38 KLRC2 KLRC3

6.49e-05172564fb2df8fea6df5947165f13978f1d1006d15b60fd
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYOM2 TTC38 KLRC2 KLRC3

6.49e-05172564e38ebb216e4ddcd008148fcbaf709b4f3c83706a
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

DDX60 TTC38 KLRC2 KLRC3

7.25e-051775640f2616a81f8fbede77c860b2126e3fa826672da3
ToppCellIIH-NK|IIH / Condition, Cell_class and T cell subcluster

TTC38 KLRC2 KLRC3 CNR2

8.78e-05186564cab1249b849013cf0334f25ee8d840f0521f4eb8
ToppCellCOVID-19_Moderate-NK_activated|World / disease group, cell group and cell class

MYOM2 TTC38 KLRC2 KLRC3

8.78e-05186564ff8f32f69516bf785224fa12f8139a95359b0279
ToppCellIIH-NK-|IIH / Condition, Cell_class and T cell subcluster

TTC38 KLRC2 KLRC3 CNR2

8.78e-051865642c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYOM2 TTC38 KLRC2 KLRC3

8.78e-05186564e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYOM2 TTC38 KLRC2 KLRC3

8.78e-051865641590fe72badffc79f1d390deb3207116ac2281bb
ToppCellmild_COVID-19_(asymptomatic)-gd_T|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

MYOM2 TTC38 KLRC2 KLRC3

8.78e-051865645fa3ed834898aa06aae15a8ade7ab93a6e4744f8
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

9.15e-05188564a29c43a91ed1364a09d5abab6efa51b8061bce74
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

MIB2 KLRC2 KLRC3 CNR2

9.15e-051885640a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCellCOVID-19_Moderate-NK_activated|COVID-19_Moderate / disease group, cell group and cell class

MYOM2 TTC38 KLRC2 KLRC3

9.34e-051895648f9f1e71857bed6d59c4b087b6a6970f30fd86be
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYOM2 TTC38 KLRC2 KLRC3

9.53e-051905641f890be1ac8613a098b271945f25a58c3c2530ab
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYOM2 TTC38 KLRC2 KLRC3

9.53e-05190564d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

9.53e-05190564600b9674197f743dea1d19d3df0fc993b6e6aa25
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

9.92e-05192564c5f77c2103841505d13e09173549811312ef2f01
ToppCellcontrol-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MIB2 MYOM2 TTC38 KLRC2

9.92e-05192564cec6ab5793953072e6b0fee370551224947dd877
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

MIB2 TTC38 KLRC2 KLRC3

9.92e-05192564e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYOM2 TTC38 KLRC2 KLRC3

9.92e-051925640cada869e852d4b9a60e95886c927fc24d072364
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

9.92e-05192564e981162f387a31111c0ae8355dbe9db5785c4838
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYOM2 TTC38 KLRC2 KLRC3

9.92e-05192564f1a843e22bdef9fdc063c21f096269eb4af590a8
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYOM2 TTC38 KLRC2 KLRC3

9.92e-05192564de937cc101a654c6699090beb7e24c430d5a19bf
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ETNK1 TTC38 KLRC2 KLRC3

9.92e-051925643b0a52e4e77ae4539a034dcb419773b8e2aa5d51
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

MED23 PUM1 BIRC6 EFR3A

1.01e-04193564abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellBac-SEP-Lymphocyte-T_NK-NK|Bac-SEP / Disease, Lineage and Cell Type

MIB2 MYOM2 TTC38 KLRC2

1.01e-041935648aa4ed2b11c6189d86e7de6bc68782fd156a37fb
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MIB2 MYOM2 TTC38 KLB

1.01e-04193564db9378c5bb5c27b321957a05dcabf40e97a3b725
ToppCell10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

MIB2 TTC38 KLRC2 KLRC3

1.03e-041945645afe7f48d3383f3dac18765f97999c8b6936dc1b
ToppCelllymphoid-NK_cell-NK_cell|World / Lineage, cell class and subclass

MIB2 MYOM2 TTC38 KLRC2

1.03e-041945647f5adc18e632109694446b8eb1543cbae62dccbe
ToppCelllymphoid-NK_cell|World / Lineage, cell class and subclass

MIB2 MYOM2 TTC38 KLRC2

1.03e-041945644bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCell10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

MIB2 TTC38 KLRC2 KLRC3

1.03e-04194564ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

1.05e-0419556449a4f58aac168fc1838bd5d2b202135cd794c28b
ToppCellCOVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class

DDX60 MYOM2 KLRC2 KLRC3

1.05e-04195564070c5d3bdbd4ea54a579c01c37fb99bcf823982e
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

1.05e-0419556498b02beafe1d418442e41f85cbf0c7b194fe5957
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MYOM2 TTC38 KLRC2 KLRC3

1.05e-04195564609732e83ab7fc3ba7dace66f5a17e46557fd6d1
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

1.05e-04195564acc603dc94ac6518adb0dffb43305b380ec75b52
ToppCellwk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MYOM2 TTC38 KLRC2 KLRC3

1.05e-041955647533822d2fe551f499b5b2fdec7172f56c79cb44
ToppCellwk_20-22-Hematologic_Lymphocytic-NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MYOM2 TTC38 KLRC2 KLRC3

1.05e-04195564a868aadca4a81cfeb773a18b0daad1ea5ece8fa8
ToppCell3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue

ANKRD11 KLRC2 KLRC3 CNR2

1.05e-041955641470f562ebcfe7da367964ecfd6c7f43bcdb4a73
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

1.05e-041955649ecae6c26a0d0607d101ccf1c38f0b23c5a256a8
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

1.05e-0419556472f42f0be53a2a61f61647118b4883e752d998a5
ToppCellT/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class

MIB2 MYOM2 TTC38 KLRC2

1.05e-041955646124e87cb9061bf8918377fb4a79084079ddfc16
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYOM2 TTC38 KLRC2 KLRC3

1.05e-041955640b50b5c71a4949f3f8fb9f5c30f9d50f53ca050d
ToppCellnormal-na-Lymphocytic_NK|normal / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

1.05e-04195564cebe79c42af5910353ba9ad7d0edb01982f772a3
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MYOM2 TTC38 KLRC2 KLRC3

1.07e-041965648e1ed30256a031bb90dac1f167e074c68efbed74
ToppCellnormal_Lymph_Node-T/NK_cells-NK|normal_Lymph_Node / Location, Cell class and cell subclass

MYOM2 TTC38 KLRC2 KLRC3

1.07e-0419656400ab4a1547752d419aa720b39b94a4ab2ede963a
ToppCelllymphoid-NK_cell|lymphoid / Lineage, cell class and subclass

MIB2 MYOM2 TTC38 KLRC2

1.07e-041965640c7fb03ef782256f61624afc5c1bfaed9f1005fb
ToppCellwk_20-22-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MYOM2 TTC38 KLRC2 KLRC3

1.07e-04196564a2f938022a080202bce5bb157d13b86b69054468
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

1.07e-0419656408714b70ddaee7d11397c1dd4a287d412edd90f7
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MIB2 MYOM2 TTC38 KLRC2

1.07e-0419656477da6b1bcab45d376eb0368f540e0ed24ce98b42
ToppCellCOVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class

MIB2 MYOM2 TTC38 KLRC2

1.07e-04196564cc1daf12de5765ba4f7002396352404b41df2012
ToppCelllymphoid-NK_cell-NK_cell|lymphoid / Lineage, cell class and subclass

MIB2 MYOM2 TTC38 KLRC2

1.07e-041965645e6238fe131e349013c60a73c99f84a6be7955ef
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

1.07e-04196564c25f90c4e5abfe7cfaa85bfe136c438a5179c978
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

1.07e-04196564bc4628d959d76c16981ac3b943f7c3fbbba49391
ToppCellmetastatic_Lymph_Node-T/NK_cells-NK|metastatic_Lymph_Node / Location, Cell class and cell subclass

MIB2 MYOM2 TTC38 KLRC2

1.07e-04196564f69f53e2ac1818b4ad0161b0bd70655e98ef65f0
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MIB2 MYOM2 TTC38 KLRC2

1.07e-04196564d451f279f4086fcf727af712f98923551181c76e
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MYOM2 TTC38 KLRC2 KLRC3

1.07e-041965645b5cf6f70534661d694f47359b6595b4580876c3
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MIB2 MYOM2 TTC38 KLRC2

1.07e-041965645bcc959db7deb34d5a32d3464367d47d4945cdaf
ToppCellControl-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type

MIB2 MYOM2 TTC38 KLRC2

1.07e-0419656465838fddc920cdcecefe823f3ce1c95a7e50e82b
ComputationalNeighborhood of IL2RB

MYOM2 TTC38 KLRC3

3.34e-0446323GNF2_IL2RB
ComputationalNeighborhood of PTPN4

MYOM2 TTC38 KLRC3

4.27e-0450323GNF2_PTPN4
Diseaseresponse to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement

MYOM2 EFR3A

1.09e-049522EFO_0020863, GO_1903492, GO_1903493
Diseasediabetic neuropathy (implicated_via_orthology)

TRPA1 BAD

2.73e-0414522DOID:9743 (implicated_via_orthology)
Diseasegastric adenocarcinoma (is_marker_for)

PTPN13 PMEPA1

1.12e-0328522DOID:3717 (is_marker_for)
DiseaseAlcoholic Intoxication, Chronic

ANKK1 NMUR2 CNR2 LRP8

1.28e-03268524C0001973
Diseasevenous thromboembolism

PAPPA2 TMLHE NLRP2 DDB2 WDR59

1.28e-03460525EFO_0004286
Diseasesleep duration, high density lipoprotein cholesterol measurement

HCAR3 PMEPA1 DDB2

1.28e-03121523EFO_0004612, EFO_0005271
DiseaseBipolar Disorder

ANKK1 HCAR3 TRPM2 ADCY2 CNR2

1.50e-03477525C0005586
DiseaseIGF-1 measurement

PAPPA2 ZNF316 PMEPA1 DDB2 KLB

1.66e-03488525EFO_0004627
DiseaseFacial wrinkling

NMUR2 RIMS2

1.95e-0337522HP_0009762
Diseaseimmunoglobulin isotype switching measurement

KLRC2 KLRC3

2.75e-0344522EFO_0010128
Diseasechildhood trauma measurement, smoking behaviour measurement

PAPPA2 RIMS2

2.87e-0345522EFO_0005671, EFO_0007979
DiseaseHDL cholesterol change measurement, physical activity

HCAR3 DDB2

5.38e-0362522EFO_0003940, EFO_0007805
Diseasetriglycerides:total lipids ratio, high density lipoprotein cholesterol measurement

HCAR3 PMEPA1 DDB2

5.76e-03206523EFO_0004612, EFO_0020947
Diseaseplatelet crit

SCARF1 USP30 DNAH3 PMEPA1 KLRC2 PGBD2

6.39e-03952526EFO_0007985
Diseaseobesity (implicated_via_orthology)

NMUR2 PUM1 WDTC1

6.48e-03215523DOID:9970 (implicated_via_orthology)
DiseaseManic Disorder

TRPM2 ADCY2

7.00e-0371522C0024713

Protein segments in the cluster

PeptideGeneStartEntry
PSHTDQHTKHWRTDN

ANKRD11

536

Q6UB99
DPNAHDKLHRTALHW

ANKRD23

136

Q86SG2
WATVTFHLPHHVLKS

BIRC6

216

Q9NR09
KHHRQAPGLLWDASH

BAD

36

Q92934
HHANVHARNKVGWTP

ANKK1

681

Q8NFD2
PVFAHLDHHKLWDPN

EFR3A

256

Q14156
LDHHKLWDPNEFAVH

EFR3A

261

Q14156
HVLWKAHQHVASLSG

CNR2

211

P34972
VISSFHKQWHSQHDP

NMUR2

341

Q9GZQ4
FDELVHWHSHKPLSD

DDX60

496

Q8IY21
LAHAVWHHSSIGQLS

MED23

1211

Q9ULK4
HSVPWHSLLNSHYEK

MYRFL

221

Q96LU7
EKHHPWAERPSSHDF

NLRP2

1046

Q9NX02
HRHFQHLTPIKAAWH

DDB2

331

Q92466
VSRAWAVVKSPHIHH

LRRC70

411

Q7Z2Q7
LHHTHIAPLESAAIW

PMEPA1

261

Q969W9
WDLHSIPSEHHEAIT

MED16

71

Q9Y2X0
AVLWQDSFSPHLKHH

PUM1

11

Q14671
SKHRWPTGDNIHAEH

PUM1

106

Q14671
EHSHSDKHPVTWQPS

RIMS2

636

Q9UQ26
SSHFQPWPKHSLKHR

PAPPA2

216

Q9BXP8
ANHLATHTWSPHLNK

BOD1L1

96

Q8NFC6
WGAAKPFAHLHHRDS

ADCY2

501

Q08462
NSPWADNTALKRHFH

CFAP298

266

P57076
WTLAAPFKEQHHHRG

DNAH3

91

Q8TD57
HHDWAVFHEESPKNN

FUT10

141

Q6P4F1
LVHVAEGSKSPWHHI

ATG9A

26

Q7Z3C6
HLLPHTHDDVGWLKT

MAN2B1

66

O00754
GPSIWDHFIHTHLKN

KLB

106

Q86Z14
KIHAIHAHNGWIPKS

ETNK1

236

Q9HBU6
ALWHTGHLQPKTHTH

FAM27D1

66

Q5T7N8
EPHHCAVAWVKNHTF

SLC22A13

46

Q9Y226
LDSAQVAHWLDHAKP

EPB41L4B

131

Q9H329
LSHAHQWVTALPHAA

POU3F3

91

P20264
LHSPEGLAVDWVHKH

LRP8

496

Q14114
SQPEHQFHHKWAILS

OTOF

346

Q9HC10
RHISHLNFTAWPDHD

PTPN13

2366

Q12923
LHWAANHKDPSAVHT

INVS

186

Q9Y283
HETRWTFHPGALTKH

MIB2

311

Q96AX9
HHPWVTINGLAFKHK

KLRC2

181

P26717
TGHPWQVSLKSDEHH

OVCH1

56

Q7RTY7
HPHHALNKISNWTAA

HCAR3

131

P49019
SHHPWVTINGLAFKH

KLRC3

181

Q07444
LSSHKLPWVTVSHHD

SCARF1

486

Q14162
LNSHTQDVKHVVWHP

CIAO1

146

O76071
WETSPDSHHHLVADA

PGBD2

201

Q6P3X8
QHHCVWPIKKAASYH

TRIM61

126

Q5EBN2
SDDQHTIVWDPLHHK

WDTC1

66

Q8N5D0
ALFLSDHNGWTALHH

TRPA1

506

O75762
HFGHENWDHQLKLAV

TRPM2

446

O94759
LSKIHGLDWHPDSEH

WDR59

191

Q6PJI9
PTDAWSVHTVAHIHE

TTC38

211

Q5R3I4
AALTRHQWAHAEEKP

ZNF316

816

A6NFI3
NHWKSQHPFHGRLTS

USP30

216

Q70CQ3
FKSLLPLAVHWHHTA

TMLHE

31

Q9NVH6
PLAVHWHHTASKSLT

TMLHE

36

Q9NVH6
VKQAWSGHHRSIVPH

USP11

366

P51784
SIFEHHAPHNEWKPH

ZNF772

236

Q68DY9
HAPHNEWKPHSNTKC

ZNF772

241

Q68DY9
EVHHKNWHEVNSSPS

MYOM2

751

P54296